A Covid-19 vaccine developed in China has shown success in mid-stage trials, according to researchers.
There are several vaccines being developed in China, some of which are already being administered.
According to the researchers, the Sinovac Biotech vaccine led to a quick immune response during trials with around 700 people.
This comes after European and US vaccines reported successful data from large late-stage trials.
Three vaccines, developed in the US, Germany, and Russia, have all released data suggesting an efficiency of more than 90%, after trials with tens of thousands of people.
China is racing to develop a Covid vaccine, and four have entered the third and final stage of clinical trials, including the one created by Sinovac Biotech.
However, the results published in the scientific journal The Lancet are only from the first and second trial phases of one of those four vaccines.
- Will there be more than one coronavirus vaccine?
- Will vaccines be compulsory? And other questions
With the pandemic reported to be almost entirely under control within China, late-stage trials of the four Chinese vaccines are being conducted in Pakistan, Saudi Arabia, Russia, Indonesia, and Brazil.
According to officials, nearly 60,000 people had received a vaccine by early November.
Source: bbc.com
